Company intelligence / Profile preview

EmboMedics

St. Paul, Minnesota, United States

Ownership: Private
Development stage: Other

Overview

EmboMedics is developing fully bioresorbable embolic microspheres for local drug delivery and vessel occlusion. Technology licensed from the University of Minnesota. In advanced R&D, not yet in clinical trials. No published human results as of latest available reports.

Therapeutic areas: CardiovascularEndocrinologyWomen's HealthHematologyOncology
Modalities: DeviceNanoparticleHydrogel-based drug delivery therapy
Industry: Therapeutic Medical Devices

Partnerships

University of Minnesota (licensing/technology transfer)

Beyond the preview

Go deeper on EmboMedics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on EmboMedics.

Explore the full profile